In8Bio (INAB) Total Liabilities (2020 - 2026)
In8Bio's Total Liabilities was $3.38 million in Q2 2026, down 18.2% from $4.13 million a year earlier and down 2.9% from the prior quarter.
Analysis
In8Bio (INAB) Total Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Total Liabilities at In8Bio came in at $4.72 million, down 26.9% from FY2024.
- Total Liabilities has now declined for four consecutive years, with a five-year compound annual growth rate of -33.9% (FY2020 to FY2025).
- In earlier years, Total Liabilities was $6.47 million in FY2024 (-26.3%), $8.77 million in FY2023 (-14.9%), $10.31 million in FY2022 (-87.2%) and $80.41 million in FY2021 (+114.5%).
- The Q2 2026 figure marks the lowest quarterly Total Liabilities in data going back to Q4 2020.
- Compared with a year earlier, Total Liabilities has declined for five straight quarters, with an average decline of 33.0% over the last seven quarters.
- The best year-over-year quarter for Total Liabilities over five years was Q3 2022 (growth of 115.3%); the worst was Q2 2022 (a decline of 88.6%).
- Per Business Quant data, INAB's Total Liabilities in the three quarters before Q2 2026 was $3.48 million (Q1 2026), $4.72 million (Q4 2025) and $3.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 115.90 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 115.64 Bn |
| 10 | In8Bio | 20.44 Mn | -57.91 Mn | - | 3.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 3.48 Mn |
| Dec 31, 2025 | 4.72 Mn |
| Sep 30, 2025 | 3.58 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 5.99 Mn |
| Dec 31, 2024 | 6.47 Mn |
| Sep 30, 2024 | 7.38 Mn |
| Jun 30, 2024 | 8.88 Mn |
| Dec 31, 2023 | 8.77 Mn |
| Sep 30, 2023 | 8.45 Mn |
| Jun 30, 2023 | 7.92 Mn |
| Mar 31, 2023 | 7.89 Mn |
| Dec 31, 2022 | 10.31 Mn |
| Sep 30, 2022 | 8.82 Mn |
| Jun 30, 2022 | 4.42 Mn |
| Mar 31, 2022 | 3.70 Mn |
| Dec 31, 2021 | 80.41 Mn |
| Sep 30, 2021 | 4.10 Mn |
| Jun 30, 2021 | 38.80 Mn |
API Access
In8Bio Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=INAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();